News|Articles|October 8, 2015
PTSM: Pharmaceutical Technology Sourcing and Management
- PTSM: Pharmaceutical Technology Sourcing and Management-11-04-2015
- Volume 11
- Issue 11
Grace Announces Silica-based Drug Delivery Platform
Author(s)Pharmaceutical Technology Editors
Grace and Formac Pharmaceuticals have announced SilSol 6035 Mesoporous Silica Gel, the first silica in the Grace silica-based drug delivery platform. The silica gel is the result of a multi-year collaboration between the companies.The platform was engineered to offer a new drug delivery option for APIs with poor aqueous solubility (BCS class 2 compounds), Grace reports and combines the company’s expertise in mesoporous silica gel and novel application methods to accelerate the screening and development of stable, amorphous-based systems.
Grace and Formac Pharmaceuticals have announced SilSol 6035 Mesoporous Silica Gel, the first silica in the Grace silica-based drug delivery platform. The silica gel is the result of a multi-year collaboration between the companies.
The platform was engineered to offer a new drug delivery option for APIs with poor aqueous solubility (BCS class 2 compounds), Grace reports and combines the company’s expertise in mesoporous silica gel and novel application methods to accelerate the screening and development of stable, amorphous-based systems.
The platform is suitable for NCE, life cycle management, reformulations, and repositioning; it can be used for a range of compounds; can generate stable formulations; and can be introduced into established manufacturing units.
The platform conforms to global monographs, is scalable from grams to tons quantities under excipient GMP manufacture; and is listed on the FDA inactive ingredient database, Grace reports.
Grace is exhibiting at CPhI Worldwide 2015, stand 7A24, Oct. 13–15, in Madrid, Spain.
Source:
Articles in this issue
about 10 years ago
New Reagents and Reactions Advance Fluorination Chemistryabout 10 years ago
CMOs Ride Continuing Strength of Small-Molecule Drug Sectorabout 10 years ago
Lubrizol Introduces Topical Filmabout 10 years ago
FDA Extends Compliance Dates for Drug Dispensersabout 10 years ago
Ashland Presents Scientific Studies for Drug Formulationabout 10 years ago
Xcelience Opens New Headquartersabout 10 years ago
Catalent Expands Cold-Chain Capacity at Shanghai Facilityabout 10 years ago
Croda's French Facility Receives EXCiPACT Certificationabout 10 years ago
Capsugel Launches enTRinsic Drug Delivery Technology PlatformNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
